TKT and neoplasm: Although a considerable delay on tumor progression was achieved by ICOVIR5-TK-L+GCV, combination treatment failed to induce complete erradication of pre-established BxPC-3 tumors; and although it doubled mean survival, long-term survival of treated mice was not achieved.